Pappa Anna-Maria, Liu Han-Yuan, Traberg-Christensen Walther, Thiburce Quentin, Savva Achilleas, Pavia Aimie, Salleo Alberto, Daniel Susan, Owens Róisín M
Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, CB30AS Cambridge, United Kingdom.
Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Olin Hall, Ithaca, New York 14853, United States.
ACS Nano. 2020 Oct 27;14(10):12538-12545. doi: 10.1021/acsnano.0c01330. Epub 2020 Jun 2.
Transmembrane proteins represent a major target for modulating cell activity, both in terms of therapeutics drugs and for pathogen interactions. Work on screening such therapeutics or identifying toxins has been severely limited by the lack of available methods that would give high content information on functionality (ideally multimodal) and that are suitable for high-throughput. Here, we have demonstrated a platform that is capable of multimodal (optical and electronic) screening of ligand gated ion-channel activity in human-derived membranes. The TREK-1 ion-channel was expressed within supported lipid bilayers, formed vesicle fusion of blebs obtained from the HEK cell line overexpressing TREK-1. The resulting reconstituted native membranes were confirmed fluorescence recovery after photobleaching to form mobile bilayers on top of films of the polymeric electroactive transducer poly(3,4-ethylenedioxythiophene) polystyrenesulfonate (PEDOT:PSS). PEDOT:PSS electrodes were then used for quantitative electrochemical impedance spectroscopy measurements of ligand-mediated TREK-1 interactions with two compounds, spadin and arachidonic acid, known to suppress and activate TREK-1 channels, respectively. PEDOT:PSS-based organic electrochemical transistors were then used for combined optical and electronic measurements of TREK-1 functionality. The technology demonstrated here is highly promising for future high-throughput screening of transmembrane protein modulators owing to the robust nature of the membrane integrated device and the highly quantitative electrical signals obtained. This is in contrast with live-cell-based electrophysiology assays (.., patch clamp) which compare poorly in terms of cost, usability, and compatibility with optical transduction.
跨膜蛋白是调节细胞活性的主要靶点,无论是在治疗药物方面还是病原体相互作用方面。由于缺乏能够提供关于功能(理想情况下是多模态)的高含量信息且适用于高通量的可用方法,筛选此类治疗药物或鉴定毒素的工作受到了严重限制。在这里,我们展示了一个能够对源自人类的膜中的配体门控离子通道活性进行多模态(光学和电子)筛选的平台。TREK-1离子通道在支持的脂质双层中表达,通过过表达TREK-1的HEK细胞系获得的泡形成囊泡融合。通过光漂白后的荧光恢复确认所得的重构天然膜在聚合物电活性换能器聚(3,4-乙撑二氧噻吩)聚苯乙烯磺酸盐(PEDOT:PSS)薄膜顶部形成可移动双层。然后使用PEDOT:PSS电极对配体介导的TREK-1与两种化合物(分别已知可抑制和激活TREK-1通道的斯帕丁和花生四烯酸)的相互作用进行定量电化学阻抗谱测量。然后使用基于PEDOT:PSS的有机电化学晶体管对TREK-1功能进行光学和电子联合测量。由于膜集成器件的稳健性质以及获得的高度定量的电信号,这里展示的技术对于未来跨膜蛋白调节剂的高通量筛选极具前景。这与基于活细胞的电生理测定(例如膜片钳)形成对比,后者在成本、可用性以及与光学转导的兼容性方面表现较差。